Letter from CGS to members of the California Institute for Regenerative Medicine's Independent Citizens Oversight Committee
By Marcy Darnovsky
| 02. 02. 2005
Dear Members of the Independent Citizens Oversight Committee:
The California public has given you the responsibility to oversee
an enormous undertaking of great potential: the largest state-funded
research program in U.S. history. The Center for Genetics and
Society supports the public funding of embryonic stem cell research
but is concerned that the new California Institute for Regenerative
Medicine (CIRM) is off to a stumbling start with regard to public
transparency and accountability. Although these are not due
to explicit decisions by your committee, you are in a position
to remedy them.
There are three particularly troubling areas of concern.
Conflict of interest regulations. This week the National
Institutes of Health - in many ways a federal analogy to your
own enterprise - announced that it is significantly strengthening
its regulations to curtail conflicts of interest. This highlights
a growing awareness that the conduct and oversight of biomedical
research requires strict protections. Yet the ICOC is failing
to make this a priority. Although it is mandated to adopt standards
"initially based" on those of the NIH for its employees
and...
Related Articles
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...